Thrombosis occurs when there is a breakdown in the balance between thr
ombogenic factors and protective mechanisms. The thrombogenic factors
may be exogenous (e.g. trauma, surgery), endogenous (e.g. cancer, vasc
ular diseases) or both (e.g. atherosclerosis, complicated pregnancy).
Defects in the protective mechanisms may be congenital (e.g. factor V
R5D6Q-mutation, deficiency of protein C, protein S or antithrombin) or
acquired (e.g. lupus anticoagulans, deficiency of antithrombin in nep
hrosis). In recent years, research in thromboembolic diseases has been
overwhelmed with new observations, rendering it worthwhile to put eff
orts into the evaluation of thrombotic mechanisms in individuals suffe
ring from or predisposed to thromboembolic diseases. Such efforts will
pave the way for more effective prophylaxis in thrombosis-prone patie
nts, more specific treatment of thrombotic diseases, and the mastering
of recurrent thrombosis.